Appointment booking for Dr. Richard Knight, MD is currently not available.Dr. Richard Knight, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Richard Knight, MD (he/him) is a Pediatrician in Hazelwood, MO with over 18 years of experience. What is your opinion of Dr. Richard Knight, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Richard Knight, MD has received over $2,520 which includes payments from the following companies:
$793.67 from Pfizer Inc.
$379.07 from Shire North American Group Inc
$191.02 from Tris Pharma Inc
$113.68 from Neos Therapeutics, LP
$111.31 from Sanofi Pasteur Inc.
$88.57 from Rhodes Pharmaceuticals L.P.
$84.91 from Ironshore Pharmaceuticals Inc.
$83.19 from FSC Laboratories, Inc.
$77.60 from sanofi-aventis U.S. LLC
$77.53 from Sobi, Inc
$74.72 from GlaxoSmithKline, LLC.
$74.16 from Lupin Pharmaceuticals, Inc
$54.52 from Galderma Laboratories, L.P.
$39.92 from Arbor Pharmaceuticals, Inc.
$38.71 from Vertical Pharmaceuticals, LLC
$38.59 from Takeda Pharmaceuticals U.S.A., Inc.
$38.15 from Kaleo, Inc.
$32.87 from Mylan Specialty L.P.
$19.88 from MedImmune, LLC
$18.59 from Wockhardt USA LLC
Payments received by Dr. Richard Knight, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!